Investigating opioid prescriptions after hip arthroscopy
Official title: Randomized Control Trial Evaluating Postoperative Opioid Demands Following Hip Arthroscopy
Run by Rush University Medical Center · NCT04094701 · Data updated 2026-11-12
This study is testing if giving fewer pain pills after hip surgery can still help patients manage their pain while using less medication.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 170 (estimated) |
| Sponsor | Rush University Medical Center Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | October 21, 2020 |
| Main results expected | November 2027 |
| Study ends | March 2028 |
| Registry record updated | August 13, 2026 |
| Trial ID | NCT04094701 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-80 who are opioid naive and undergoing primary hip arthroscopy.
✕Probably not a fit
Patients with a history of opioid use, chronic pain conditions, or other significant health issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial is a prospective, single-blinded, randomized controlled trial that examines the impact of different opioid prescription amounts following primary hip arthroscopy. Participants will be randomly assigned to receive either a reduced opioid regimen of 5 Norco pills along with gabapentin and Tylenol or the standard regimen of 30 Norco pills. The study will track postoperative pain scores, total morphine equivalents used, and patient-reported outcomes over a 12-month follow-up period. The goal is to determine if a reduced opioid prescription can effectively manage pain while minimizing opioid use.
Why it matters
Potential benefit: If successful, this study could lead to safer postoperative pain management strategies that reduce reliance on opioids.
How similar studies have gone: Other studies have shown promising results with reduced opioid prescribing strategies, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients age 18-80 years * English speaking * Opioid naive patient (defined as not taking opioid pills within 6 weeks prior to surgery), confirmed by checking the Illinois Prescription monitoring program * Primary hip arthroscopy * Written and informed consent for study participation Exclusion Criteria: * Minors (\<18 years of age) * Opioid tolerant patients * Revision surgery * Prior infections of the operative joint * History of active malignancy within the past 5 years * Chronic pain conditions including low back pain, chronic pain syndrome, fibromyalgia * History of alcohol or other substance use disorder * Other disease states including rheumatologic conditions, diabetes mellitus, hypo/hyperthyroidism, depression, anxiety * Grade IV chondral defects
Where it's running
-
Rush University Medical Center
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Carla M. Edwards
- Email: carla_edwards@rush.edu
- Phone: 312-563-5735
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood flow restriction therapy after hip surgery
This study is testing if a special therapy that restricts blood flow can help people recover stronger and faster after hip surgery for certain injuries.
-
Serratus vs Erector Spinae Block for Pain After Unilateral Breast Surgery
This trial tests whether serratus posterior superior intercostal plane block or erector spinae plane block reduces chronic pain 3 months after unilateral breast surgery in adult women.
-
Using mHealth to Help Black Adults in the Midwest With Opioid/Stimulant Use and Mood Symptoms
This study tests a mobile health program to support recovery and mood in Black adults who use opioids or stimulants and are seeking treatment.
-
Targeting alcohol-opioid co-use among young adults with a new mobile health tool
A mobile health app is being tested to help young adults reduce drinking and opioid use when they occur together.
-
Dexa vs Dexmedetomidine with Bupivacaine in TAP Block for Laparotomy Analgesia
This study tests whether adding dexamethasone or dexmedetomidine to bupivacaine in a TAP block improves postoperative pain control after laparotomy.
-
Stress response with desflurane versus opioid-free TIVA during weight-loss surgery
This study will test whether adding the inhaled anesthetic desflurane to opioid-free anesthesia changes the body's perioperative stress response in people having bariatric (weight-loss) surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.